Publications

  1. Logie N, Jimenez R, Rulenzas N, Linden K, Ciagone D, Ghosh S, Xu Y, Lefresne S, Wong E, son CH, Shih HA, Wong W, Tyldesley S, Dennis K, Chow E, Fairchild A. Estimating prognosis at the time of repeat whole brain radiotherapy for multiple brain metastases: The ReRT Score. Advances in Radiation Oncology.2017;
  2. Liu W, Patel SH, Harrington DP, Hu Y, Ding X, Shen J, Halyard MY, Schild SE, Wong WW, Ezzell GE, Bues M. Exploratory study of the association of volumetric modulated arc therapy (VMAT) plan robustness with local failure in head and neck cancer. J Appl Clin Med Phys 2017 Jul; 18 (4):76-83 Epub 2017 May 14
    View PubMed
  3. Gamez ME, Lal D, Halyard MY, Wong WW, Vargas C, Ma D, Ko SJ, Foote RL, Patel SH. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience. Head Neck 2017 May 31 [Epub ahead of print]
    View PubMed
  4. Wong WW, Anderson EM, Mohammadi H, Daniels TB, Schild SE, Keole SR, Choo CR, Tzou KS, Bryce AH, Ho TH, Quevedo FJ, Vora SA. Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer 2017 Apr 26 [Epub ahead of print]
    View PubMed
  5. Schild MH, Schild SE, Wong WW, Vora SA, Keole SR, Vargas CE, Daniels TB, Ezzell GA, Nguyen BD, Roarke MC. A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT. Int J Radiat Oncol Biol Phys 2017 Apr 01; 97 (5):1021-1025 Epub 2017 Feb 01
    View PubMed
  6. Gamez ME, Halyard MY, Hinni ML, Hayden RE, Nagel TH, Vargas CE, Wong WW, Curtis KK, Zarka MA, Ma D, Patel SH. Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer. Ann Otol Rhinol Laryngol 2017 Mar; 126 (3):185-191 Epub 2017 Jan 05
    View PubMed
  7. Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy. J Cancer Ther 2017 Feb; 8 (2):73-85 Epub 2017 Feb 06
    View PubMed
  8. Chang JM, Kosiorek HE, Dueck AC, Casey WJ, Rebecca AM, Mahabir R, Patel SH, Keole SR, Wong WW, Vargas CE, Halyard MY, Gray RJ, Wasif N, Stucky CH, Pockaj BA. Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center. Am J Surg 2016 Dec; 212 (6):1201-1210 Epub 2016 Sept 29
    View PubMed
  9. Liu W, Patel SH, Shen JJ, Hu Y, Harrington DP, Ding X, Halyard MY, Schild SE, Wong WW, Ezzell GA, Bues M. Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancer. Pract Radiat Oncol 2016 Nov - Dec; 6 (6):e269-e275 Epub 2016 Feb 13
    View PubMed
  10. Lee RJ, Tzou KS, Heckman MG, Hobbs CJ, Rawal B, Diehl NN, Peterson JL, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Wong W, Schild S, Pisansky TM, Buskirk SJ. Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy. BJU Int 2016 Aug; 118 (2):236-42 Epub 2015 Aug 22
    View PubMed
  11. Curtis KK, Wong WW, Ross HJ. Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neck. Crit Rev Oncol Hematol 2016 Jul; 103:86-98 Epub 2016 May 16
    View PubMed
  12. Liu X, Li J, Wu T, Schild SE, Schild MH, Wong W, Vora S, Fatyga M. Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade >= 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol 2016 Jun; 5 (3) Epub 2016 June 13
    View PubMed
  13. Liu X, Fatyga M, Herman M, Vora S, Wong W, Schild S, Schild M, Li J, Wu T. SU-D-204-03: Comparison of Patient Positioning Methods Through Modeling of Acute Rectal Toxicity in Intensity Modulated Radiation Therapy for Prostate Cancer. Does Quality of Data Matter More Than the Quantity? Med Phys 2016 Jun; 43 (6):3332
    View PubMed
  14. Liu W, Schild SE, Chang JY, Liao Z, Chang YH, Wen Z, Shen J, Stoker JB, Ding X, Hu Y, Sahoo N, Herman MG, Vargas C, Keole S, Wong W, Bues M. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys 2016 May 01; 95 (1):523-33 Epub 2015 Nov 10
    View PubMed
  15. Curtis KK, Ross HJ, Garrett AL, Jizba TA, Patel AB, Patel SH, Wong WW, Halyard MY, Ko SJ, Kosiorek HE, Foote RL. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic. Radiat Oncol 2016 Apr 09; 11:55
    View PubMed
  16. Dirksen SR, Belyea MJ, Wong W, Epstein DR. Transitions in Symptom Cluster Subgroups Among Men Undergoing Prostate Cancer Radiation Therapy. Cancer Nurs 2016 Jan-Feb; 39 (1):3-11
    View PubMed
  17. Parikh P, Pockaj B, Wasif N, Halyard M, Wong W, Kosiorek HE, Dueck AC, Gray R. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast. Ann Surg Oncol 2015 Dec; 22 Suppl 3:S516-21 Epub 2015 May 19
    View PubMed
  18. Linnaus ME, Dueck AC, Kosiorek HE, Gray RJ, Wasif N, Northfelt DW, Anderson KS, McCullough AE, Wong WW, Halyard MY, Patel SH, Pockaj BA. Regional recurrence in the era of sentinel lymph node biopsy. Am J Surg 2015 Dec; 210 (6):1155-60; discussion 1160-1 Epub 2015 Sept 28
    View PubMed
  19. Liu X, Fatyga M, Li J, Schild M, Schild S, Vora S, Wong W, Wu T. TH-AB-304-02: Fitting Grade>=2(2+) Acute Rectal Complication Rates in Prostate Cancer Patients to Lyman Kutcher Burman (LKB) and Logistic Regression NTCP Models Using Dosimetry and Patient Specific Characteristics. Med Phys. 2015 Jun; 42(6):3700.
    View PubMed
  20. Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S, Wu Q, Ko SJ, Halyard MY. Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg. 2015 Apr; 141(4):335-40.
    View PubMed
  21. Liu W, Liao Z, Schild SE, Liu Z, Li H, Li Y, Park PC, Li X, Stoker J, Shen J, Keole S, Anand A, Fatyga M, Dong L, Sahoo N, Vora S, Wong W, Zhu XR, Bues M, Mohan R. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers. Pract Radiat Oncol 2015 Mar-Apr; 5 (2):e77-86 Epub 2014 Sept 11
    View PubMed
  22. Ho TH, Nateras RN, Yan H, Park JG, Jensen S, Borges C, Lee JH, Champion MD, Tibes R, Bryce AH, Carballido EM, Todd MA, Joseph RW, Wong WW, Parker AS, Stanton ML, Castle EP. A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. PLoS One 2015; 10 (7):e0132831 Epub 2015 July 16
    View PubMed
  23. Schild MH, Schild SE, Wong WW, Vora SA, Silva AC, Silva AC, Daniels TB, Keole SR. Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost. OMICS J Radiol 2014 Dec; 3 (4)
    View PubMed
  24. Schild MH, Wong WW, Valdez R, Leis JF. Primary pulmonary classical Hodgkin lymphoma: a case report. J Surg Oncol. 2014 Sep; 110(3):341-4. Epub 2014 Apr 29.
    View PubMed
  25. Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RL. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014 Aug; 15(9):1027-38. Epub 2014 Jun 26.
    View PubMed
  26. Wong WW, Pockaj BA, Vora SA, Halyard MY, Gray RJ, Schild SE. Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. Breast J. 2014 Mar-Apr; 20(2):125-30. Epub 2013 Dec 26.
    View PubMed
  27. Paly JJ, Hallemeier CL, Biggs PJ, Niemierko A, Roeder F, Martinez-Monge R, Whitson J, Calvo FA, Fastner G, Sedlmayer F, Wong WW, Ellis RJ, Haddock MG, Choo R, Shipley WU, Zietman AL, Efstathiou JA. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 Mar 1; 88(3):618-23. Epub 2014 Jan 8
    View PubMed
  28. Heckman MG, Tzou KS, Thomas CS, Pisansky TM, Schild SE, Wong WW, Lee RJ, Bois MC, Brinjikji W, Peterson JL, Daugherty LC, Ko SJ, Buskirk SJ. Utilization of PSA Measurement at Three Months Following Salvage Radiation Therapy to Predict Future Treatment Response. J Radiation Oncology.2014;3(1)81-87.
  29. Patel SH, Hinni ML, Hayden RE, Wong WW, Dueck AC, Zarka MA, Curtis KK, Halyard MY. Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience. Head Neck 2014 Feb; 36 (2):220-5 Epub 2013 Mar 26
    View PubMed
  30. Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol 2014; 16 (2):67-75
    View PubMed
  31. Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer. J Urol. 2013 Aug; 190(2):521-6. Epub 2013 Feb 13.
    View PubMed
  32. Wong WW, Schild SE, Vora SA, Ezzell GA, Nguyen BD, Ram PC, Roarke MC. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging. Int J Radiat Oncol Biol Phys 2011 Nov 15; 81 (4):e423-9 Epub 2011 Apr 07
    View PubMed
  33. Wong NW, Wong WW, Karlin NJ, Gray RJ. Radiation recall secondary to adjuvant docetaxel after balloon-catheter based accelerated partial breast irradiation. Radiography. 2010; 16(3):253-5 Epub 2010 Apr 28.
    View PubMed
  34. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer. 2009 Dec 1; 115(23):5596-606.
    View PubMed
  35. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy 2009 Jul-Sep; 8 (3):309-12 Epub 2009 Feb 12
    View PubMed
  36. Schild MH, Wong WW, Vora SA, Ward LD, Nguyen BD. Embolization of an iodine-125 radioactive seed from the prostate gland into the right ventricle: An unusual pattern of seed migration. Radiography. 2009; 15(2):179-81.
    View PubMed
  37. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29.
    View PubMed
  38. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 2006 Nov; 176 (5):2020-4
    View PubMed
  39. Lyons MK, Drazkowski JF, Wong WW, Fitch TR, Nelson KD. Metastatic prostate carcinoma mimicking meningioma: case report and review of the literature. Neurologist. 2006 Jan; 12(1):48-52.
    View PubMed
  40. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7.
    View PubMed
  41. Schwartz DJ, Schild SE, Wong WW, Vora SA. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005 Jan 1; 61(1):60-3.
    View PubMed
  42. Drazkowski JF, Fitch TR, Lyons MK, Nelson KD, Wong WW. Metastatic prostate carcinoma mimicking meningioma. African Journal of Neurological Sciences. 2005; 24(2):96-100.
    View PubMed
  43. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology. 2004 Oct; 64(4):760-4.
    View PubMed
  44. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Sep 1; 60(1):24-9.
    View PubMed
  45. Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC). Med Dosim. 2004 Fall; 29(3):196-203.
    View PubMed
  46. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug; 27(4):389-94.
    View PubMed
  47. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1530-5.
    View PubMed
  48. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol. 2003 Nov; 170(5):1833-7.
    View PubMed
  49. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):729-34.
    View PubMed
  50. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol. 2002 May; 80(1):19-25; discussion 26.
    View PubMed
  51. Ezzell GA, Schild SE, Wong WW. Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy. J Appl Clin Med Phys 2001 Spring; 2 (2):59-68
    View PubMed
  52. Schild SE, Nisi K, Scheithauer BW, Wong WW, Lyons MK, Schomberg PJ, Shaw EG. The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1998 Dec 1; 42(5):953-8.
    View PubMed
  53. Schild SE, Stafford SL, Brown PD, Wood CP, Scheithauer BW, Schomberg PJ, Wong WW, Lyons MK, Shaw EG. The results of radiotherapy for brainstem tumors. J Neurooncol. 1998 Nov; 40(2):171-7.
    View PubMed
  54. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998 Sep 1; 42(2):351-60.
    View PubMed
  55. Schild SE, Wong W. The role of retrograde urethrography in the planning of prostate cancer radiotherapy. Med Dosim 1997 Summer; 22 (2):83-6
    View PubMed
  56. Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW, Lyons MK. Central neurocytomas. Cancer. 1997 Feb 15; 79(4):790-5.
    View PubMed
  57. Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys. 1997 Jan 1; 37(1):51-8.
    View PubMed
  58. Schild SE, Scheithauer BW, Haddock MG, Wong WW, Lyons MK, Marks LB, Norman MG, Burger PC. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer. 1996 Dec 15; 78(12):2564-71.
    View PubMed
  59. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9.
    View PubMed
  60. Schild SE, Haddock MG, Scheithauer BW, Marks LB, Norman MG, Burger PC, Wong WW, Lyons MK, Schomberg PJ. Nongerminomatous germ cell tumors of the brain. Int J Radiat Oncol Biol Phys. 1996 Oct 1; 36(3):557-63.
    View PubMed
  61. Schild SE, Wong WW, Novicki DE, Ferrigni RG, Swanson SK. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay. Urology. 1996 Jun; 47(6):878-81.
    View PubMed
  62. Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):585-90.
    View PubMed
  63. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):535-41.
    View PubMed
  64. Wong WW, Schild SE, Martenson JA. Role of radiation therapy and fluoropyrimidines in the treatment of gastrointestinal malignancies. Cancer Control. 1996; 3(4):319-328.
    View PubMed
  65. Schild SE, Wong WW, Grado GL, Buskirk SJ, Ferrigni RL. The Use of Radiotherapy for Patients with Isolated Elevation of Serum PSA Levels following Radical Prostatectomy. Radiology. 1995; 294:293.
  66. Mundt AJ, Awan A, Sibley GS, Simon M, Rubin SJ, Samuels B, Wong W, Beckett M, Vijayakumar S, Weichselbaum RR. Conservative Surgery and Adjuvant Irradiation in the Management of Adult Soft Tissue Sarcoma: Clinical and Radiobiological Results. Int J RadiatOncolBiol Phys. 1995; 32:977-986.
  67. Wong WW, Pluth JR, Grado GL, Schild SE, Sanderson DR. Liposarcoma of the pleura. Mayo Clin Proc. 1994 Sep; 69(9):882-5.
    View PubMed
  68. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc. 1994 Jul; 69(7):613-9.
    View PubMed
  69. Wong WW, Mick R, Haraf D, Weichselbaum R, Vokes E. Time-dose Analysis for Local Tumor Control Following Alternate Week Concomitant Radiation and Chemotherapy of Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 1994; 29:153-162.
    View PubMed
  70. Wong WW, Vijayakumar S, Weichselbaum RR. Prognostic indicators in node-negative early stage breast cancer. Am J Med. 1992 May; 92(5):539-48.
    View PubMed
  71. Wong WW, Chen G. OTCs and the pregnant woman. How hazardous? Mod Med. 1983 Jan; 51:223-225.